Month: May 2022
-
Venture Investor Funds Cell Therapy Targeting Tech
A venture capital company is funding biomedical engineering research to improve the reach and targeting of cell therapies to more diseases.
-
Precision Antibacterial Company Raises $35M in New Funds
A biotechnology company creating targeted antibacterial and microbiome treatments aided by gene editing is raising $35 million in new venture funds.
-
Companies Partner on Implanted Diabetes Beta Cell Device
A company developing implants that release cell therapies is collaborating with a producer of regenerative stem cells to dispense insulin for people with diabetes.
-
Trial Shows Gene Therapy Results with Sickle Cell Disease
Early results from a clinical trial show an experimental gene transfer therapy largely reduces painful events from sickle cell disease for one to two years.
-
Infographic – Synthetic Opioids Driving Overdose Deaths
While Covid-19 may grab health headlines in the U.S., the opioid epidemic is not going away, and shifting from prescription to synthetic compounds.
-
Early Trial Data Show Crispr Cancer Therapy Response
Initial results from a clinical trial show non-Hodgkin lymphoma patients receiving low doses of gene-edited T-cells achieve a clinical response, but with some adverse effects.
-
Roche, Global Fund to Build Local Diagnostic Processes
The medical products company Roche is partnering with the Global Fund to develop systems and processes for disease diagnostics in low-resource regions.
-
Trial Set for Ingested Colon Cancer Detection Capsule
A clinical trial is set to begin assessing an electronic capsule designed to detect and transmit images from the gut to detect early cancer-causing polyps.
-
Small Biz Grant Funds Mental Health App Clinical Trial
National Institute of Mental Health is funding a clinical trial to evaluate a home-based mobile app that works online with a clinician to treat depression.
-
AI-Aided Collaboration to Discover Neuro Disease Drugs
Two biotechnology and health technology companies are discovering precision treatments for neurological disorders with simulation models for individual patients.